As of April 16, 2025, bioMérieux (BIM.PA) has a market cap of $15.72 billion USD. According to our data, bioMérieux is ranked No.1121 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $15.72 B |
13.91%
|
Dec 31, 2024 | $13.80 B |
3.81%
|
Dec 29, 2023 | $13.29 B |
3.68%
|
Dec 30, 2022 | $12.82 B |
-20.89%
|
Dec 31, 2021 | $16.20 B |
8.98%
|
Dec 31, 2020 | $14.87 B |
46.08%
|
Dec 31, 2019 | $10.18 B |
38.67%
|
Dec 31, 2018 | $7.34 B |
-22.68%
|
Dec 29, 2017 | $9.49 B |
58.73%
|
Dec 30, 2016 | $5.98 B |
29.80%
|
Dec 30, 2015 | $4.61 B |
29.86%
|
Dec 31, 2014 | $3.55 B |
13.79%
|
Dec 31, 2013 | $3.12 B |
7.58%
|
Dec 28, 2012 | $2.90 B |
32.20%
|
Dec 30, 2011 | $2.19 B |
-26.63%
|
Dec 30, 2010 | $2.99 B |
-5.62%
|
Dec 31, 2009 | $3.17 B |
37.90%
|
Dec 31, 2008 | $2.30 B |
-23.30%
|
Dec 31, 2007 | $2.99 B |
55.04%
|
Dec 29, 2006 | $1.93 B |
17.14%
|
Dec 30, 2005 | $1.65 B |
39.00%
|
Dec 31, 2004 | $1.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Thermo Fisher Scientific
TMO
|
$166.47 B |
0.002 M
|
![]() USA
|
![]() Danaher
DHR
|
$135.88 B |
0.003 M
|
![]() USA
|
![]() Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$58.01 B |
-0.001 M
|
![]() USA
|
![]() Agilent Technologies
A
|
$29.40 B |
-0.001 M
|
![]() USA
|
![]() Hologic
HOLX
|
$13.06 B |
0.000 M
|
![]() USA
|
![]() Bio-Rad Laboratories
BIO
|
$6.82 B |
1.204 B
|
![]() USA
|
![]() Illumina
ILMN
|
$11.80 B |
-0.000 M
|
![]() USA
|
![]() Qiagen
QGEN
|
$8.98 B |
0.000 M
|
![]() Netherlands
|
![]() Charles River Laboratories
CRL
|
$5.20 B |
-0.000 M
|
![]() USA
|
![]() Bruker
BRKR
|
$5.82 B |
0.000 M
|
![]() USA
|
Market Cap | = | BIM.PA Stock Price | * | BIM.PA Shares Outstanding |
= | $133.27 | * | 0.12 B | |
= | $15.72 B |